Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Machine Learning for the Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Complication Risk

NCT06277414 is registered in ClinicalTrials.gov with The First Affiliated Hospital of University of South China as lead sponsor.

NCT NCT06277414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06277414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Machine Learning for the Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Complication Risk
Lead sponsor
The First Affiliated Hospital of University of South China
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2018
Completion date
December 31, 2024
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endoscopic retrograde cholangiopancreatography